Evidence supporting the use of: Alpha-Linolenic Acid
For the health condition: Rheumatoid Arthritis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Alpha-Linolenic Acid (ALA) is an omega-3 fatty acid found in plant sources such as flaxseed, chia seeds, and walnuts. Its use in supporting or treating Rheumatoid Arthritis (RA) is based on its anti-inflammatory properties, as RA is characterized by chronic inflammation of the joints. Scientific studies have shown that omega-3 fatty acids, particularly EPA and DHA from fish oils, may have beneficial effects in reducing RA symptoms, such as joint pain and morning stiffness. However, the evidence for ALA specifically is less robust. ALA is a precursor to EPA and DHA, but the conversion rate in humans is low (typically less than 10%), which limits its effectiveness compared to marine-derived omega-3s.

Some small clinical trials and observational studies suggest that higher dietary intake of ALA may be associated with modest reductions in inflammation and improvement of RA symptoms, but results are inconsistent and often not statistically significant. Systematic reviews and meta-analyses have concluded that while there is some biological plausibility for ALA’s benefit in RA, the clinical evidence is weak and insufficient to make strong recommendations for its use as a primary therapeutic agent for RA. Major guidelines do not endorse ALA supplementation specifically for RA management. Thus, while there is some scientific interest and a plausible mechanism, the direct evidence supporting ALA for RA is limited and rates low on the evidence scale.

More about Alpha-Linolenic Acid
More about Rheumatoid Arthritis

Products containing Alpha-Linolenic Acid

We currently have no products on Vitabase that contain this ingredient.